|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 279.55 INR | -0.85% |
|
+4.27% | +3.35% |
| 22/05 | Dishman Carbogen Amcis Limited, Q4 2025 Earnings Call, May 22, 2025 | |
| 22/05 | Dishman Carbogen Amcis Limited Reports Earnings Results for the Full Year Ended March 31, 2025 | CI |
| Capitalization | 3.41TCr 40Cr 34Cr 32Cr 29Cr 54Cr 61Cr 376.28Cr 146.41Cr 1.56TCr 148.86Cr 145.65Cr 5.71TCr | P/E ratio 2023 |
-65.6x | P/E ratio 2024 | -24.1x |
|---|---|---|---|---|---|
| Enterprise value | 5.3TCr 62Cr 53Cr 50Cr 45Cr 84Cr 94Cr 583.58Cr 227.07Cr 2.42TCr 230.87Cr 225.89Cr 8.86TCr | EV / Sales 2023 |
1.6x | EV / Sales 2024 | 2.13x |
| Free-Float |
29.66% | Yield 2023 * |
-
| Yield 2024 | - |
More valuation ratios
* Estimated data
More news
Last Transcript: Dishman Carbogen Amcis Limited
| 1 day | -0.85% | ||
| 1 week | +4.27% | ||
| Current month | +4.97% | ||
| 1 month | +33.98% | ||
| 3 months | +33.19% | ||
| 6 months | -0.03% | ||
| Current year | +3.35% |
| 1 week | 266.6 |  | 291.5 |
| 1 month | 211.2 | | 291.5 |
| Current year | 178 | | 298.7 |
| 1 year | 155.05 | | 307.98 |
| 3 years | 80 | | 307.98 |
| 5 years | 80 | | 307.98 |
| 10 years | 46.05 | | 396.4 |
| Manager | Title | Age | Since |
|---|---|---|---|
| Chief Executive Officer | 39 | 07/02/2019 | |
Harshil R. Dalal
DFI | Director of Finance/CFO | 43 | 28/11/2018 |
Paolo Armanino
COO | Chief Operating Officer | - | - |
| Director | Title | Age | Since |
|---|---|---|---|
| Director/Board Member | 74 | 17/03/2017 | |
| Director/Board Member | 39 | 17/03/2017 | |
| Director/Board Member | - | 01/04/2025 |
| Name | Weight | AuM | 1st Jan change | |
|---|---|---|---|---|
| 0% | 89 M€ | -4.70% | - |
| Change | 5d. change | 1-year change | 3-years change | Capi.($) | ||
|---|---|---|---|---|---|---|
| -0.85% | +4.27% | +60.91% | +126.54% | 52Cr | ||
| +0.90% | +6.43% | -7.24% | +181.30% | 73TCr | ||
| +0.28% | +1.34% | +8.01% | -8.03% | 38TCr | ||
| -0.58% | +5.27% | -47.31% | +34.04% | 36TCr | ||
| -0.70% | +0.66% | +14.72% | +37.05% | 34TCr | ||
| -1.06% | +0.56% | +9.72% | -12.79% | 27TCr | ||
| -0.93% | +0.08% | +3.08% | +17.37% | 24TCr | ||
| -0.40% | +1.89% | -11.35% | +12.37% | 23TCr | ||
| -0.13% | +3.47% | -36.84% | -3.87% | 21TCr | ||
| -0.70% | +1.68% | -1.10% | +24.69% | 16TCr | ||
| Average | -0.73% | +3.34% | -0.74% | +40.87% | 29.07TCr | |
| Weighted average by Cap. | -0.59% | +3.95% | -7.29% | +55.27% |
| 2023 | 2024 | |
|---|---|---|
| Net sales | 2.41TCr 28Cr 24Cr 23Cr 21Cr 38Cr 43Cr 265.9Cr 103.46Cr 1.1TCr 105.19Cr 102.92Cr 4.04TCr | 2.62TCr 30Cr 26Cr 25Cr 22Cr 41Cr 47Cr 288.25Cr 112.16Cr 1.2TCr 114.04Cr 111.57Cr 4.37TCr |
| Net income | -30Cr -34.61L -29.94L -28.09L -25.46L -47L -53.17L -3.28Cr -1.28Cr -14Cr -1.3Cr -1.27Cr -50Cr | -153.45Cr -1.78Cr -1.54Cr -1.45Cr -1.31Cr -2.42Cr -2.74Cr -17Cr -6.58Cr -70Cr -6.69Cr -6.55Cr -256.62Cr |
| Net Debt | 1.9TCr 22Cr 19Cr 18Cr 16Cr 30Cr 34Cr 209.38Cr 81Cr 869.84Cr 83Cr 81Cr 3.18TCr | 1.88TCr 22Cr 19Cr 18Cr 16Cr 30Cr 34Cr 207.3Cr 81Cr 861.2Cr 82Cr 80Cr 3.15TCr |
More financial data
* Estimated data
Employees
1,132
Sector
Pharmaceuticals
Calendar
| Date | Price | Change | Volume |
|---|---|---|---|
| 13/25/13 | 279.55 ₹ | -0.85% | 13,27,573 |
| 12/25/12 | 281.95 ₹ | -2.30% | 6,18,392 |
| 11/25/11 | 288.60 ₹ | +4.79% | 13,10,012 |
| 10/25/10 | 275.40 ₹ | +0.47% | 6,13,395 |
| 09/25/09 | 274.10 ₹ | +2.24% | 4,47,943 |
Delayed Quote NSE India S.E., June 13, 2025 at 05:19 pm IST
More quotes
Quarterly revenue - Rate of surprise
- Stock Market
- Equities
- DCAL Stock
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition
Stay in the current country edition